Fundamentals Overview
Colgate-Palmolive Company is in the middle of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Intrinsic value (DCF)
+40.1% upside vs price
Profitability
Risk (Beta)
0.33 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +40.1% upside vs price · Analyst grade: B+ · Sentiment improving (4 upgrades) · 3M vs Consumer Defensive sector: +7%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 9, Equal Weight: 5, Hold: 3, Outperform: 3, Overweight: 9, Underweight: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $116.94; current price is $83.49. That’s a +40.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 31.53 |
| DCF value (model) | $116.94 (40.1% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | N/A |
| P/S (TTM) | 3.28 |
| P/FCF (TTM) | 18.42 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1 |
| Quick Ratio (TTM) | 0.64 |
| Cash Ratio (TTM) | 0.22 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 10.46% |
| Gross margin (TTM) | 60.11% |
| Operating margin (TTM) | 21.31% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for CL.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| B of A Securities | maintain | Buy | Buy | 2026-04-10 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-04-08 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-04-08 |
| UBS | maintain | Buy | Buy | 2026-04-07 |
| Deutsche Bank | upgrade | Hold | Buy | 2026-03-30 |
| Barclays | maintain | Equal Weight | Equal Weight | 2026-02-03 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-02-02 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-02 |
| Deutsche Bank | maintain | Hold | Hold | 2026-02-02 |
| Jefferies | maintain | Hold | Hold | 2026-02-02 |
| B of A Securities | maintain | Buy | Buy | 2026-02-02 |
| Citigroup | maintain | Buy | Buy | 2026-02-02 |
| JP Morgan | maintain | Overweight | Overweight | 2026-02-02 |
| Morgan Stanley | maintain | Overweight | Overweight | 2026-02-02 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-02 |
| JP Morgan | maintain | Overweight | Overweight | 2026-01-16 |
| UBS | maintain | Buy | Buy | 2026-01-14 |
| Wells Fargo | upgrade | Underweight | Equal Weight | 2026-01-13 |
| TD Cowen | maintain | Buy | Buy | 2026-01-08 |
| Piper Sandler | upgrade | Neutral | Overweight | 2026-01-07 |
| JP Morgan | maintain | Overweight | Overweight | 2025-12-18 |
| Argus Research | downgrade | Buy | Hold | 2025-12-11 |
| RBC Capital | upgrade | Sector Perform | Outperform | 2025-12-09 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-11-04 |
| Citigroup | maintain | Buy | Buy | 2025-11-03 |
| JP Morgan | maintain | Overweight | Overweight | 2025-11-03 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-11-03 |
| Wells Fargo | maintain | Underweight | Underweight | 2025-11-03 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-11-03 |
| UBS | maintain | Buy | Buy | 2025-11-03 |